Company intelligence / Profile preview

ReachBio Research Labs

Seattle, Washington, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

ReachBio Research Labs is a preclinical contract research organization providing primary cell biology-based assays and services to support drug discovery and development, with particular expertise in blood and bone marrow systems, hematotoxicity prediction, immunology, immuno-oncology, and specialized platforms such as ADC off-target toxicity/linker stability and fetal hemoglobin induction screens for sickle cell disease.[1][3][5]

Therapeutic areas: HematologyImmunologyOtherOncology
Modalities: AntibodyAntibody-drug conjugateSmall molecule
Industry: Contract Research Organization

Partnerships

abc biopply (co-marketing partnership for preclinical test models and predictive assay portfolio)[1]

Beyond the preview

Go deeper on ReachBio Research Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReachBio Research Labs.

Explore the full profile